Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieron Dunleavy

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Blood|February 6, 2025
The dark zone of CNS relapse in DLBCLKieron Dunleavy
Journal of Oncology Practice|March 11, 2016
Optimal Management of Double-Hit LymphomaKieron Dunleavy
Onkologie|October 16, 2008
Angioimmunoblastic T-cell lymphoma (AILT): a unique clinical and pathobiological entityKieron Dunleavy
Journal of Oncology Practice|November 14, 2018
Approach to the Diagnosis and Treatment of Adult Burkitt's LymphomaKieron Dunleavy
Oncology (Williston Park, N.Y.)|June 17, 2017
Management of Primary Mediastinal B-Cell Lymphoma and Gray Zone LymphomaKieron Dunleavy
Blood|June 2, 2018
Liquid biopsy for Hodgkin: a game changer?Kieron Dunleavy
Hematology. American Society of Hematology. Education Program|December 10, 2021
Double-hit lymphoma: optimizing therapyKieron Dunleavy
Current Treatment Options in Oncology|December 5, 2015
Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCLKieron Dunleavy
Hematology. American Society of Hematology. Education Program|December 10, 2017
Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategiesKieron Dunleavy
Clinical Advances in Hematology & Oncology : H&O|September 27, 2017
Advances in the management of primary central nervous system lymphomaKieron Dunleavy
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Blood|February 6, 2025
The dark zone of CNS relapse in DLBCLKieron Dunleavy
Journal of Oncology Practice|March 11, 2016
Optimal Management of Double-Hit LymphomaKieron Dunleavy
Onkologie|October 16, 2008
Angioimmunoblastic T-cell lymphoma (AILT): a unique clinical and pathobiological entityKieron Dunleavy
Journal of Oncology Practice|November 14, 2018
Approach to the Diagnosis and Treatment of Adult Burkitt's LymphomaKieron Dunleavy
Oncology (Williston Park, N.Y.)|June 17, 2017
Management of Primary Mediastinal B-Cell Lymphoma and Gray Zone LymphomaKieron Dunleavy
Blood|June 2, 2018
Liquid biopsy for Hodgkin: a game changer?Kieron Dunleavy
Hematology. American Society of Hematology. Education Program|December 10, 2021
Double-hit lymphoma: optimizing therapyKieron Dunleavy
Current Treatment Options in Oncology|December 5, 2015
Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCLKieron Dunleavy
Hematology. American Society of Hematology. Education Program|December 10, 2017
Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategiesKieron Dunleavy
Clinical Advances in Hematology & Oncology : H&O|September 27, 2017
Advances in the management of primary central nervous system lymphomaKieron Dunleavy
Pageof 13